Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Infliximab Produits

(Infliximab)

Catégories

antibodies-online.com est synonyme de produits de recherche de haute qualité. Cherchez, trouvez et commandez des outils avec des données de validation étendues, des images, des références. Notre service clientèle scientifique est toujours à votre disposition si vous avez des questions sur la sélection ou l'application de nos produits.

Infliximab recommandé Anticorps

Produit
Reactivity
Application
Validations
N° du produit
Quantité
Fiche technique
Reactivity Human
Application ELISA
Validations
N° du produit ABIN7514439
Quantité 40 μg
Fiche technique Fiche technique

Infliximab recommandé Kits ELISA

Produit
Reactivity
Analytical Method
Validations
N° du produit
Quantité
Fiche technique
Reactivity Human, Monkey, Mouse, Rat
Analytical Method Quantitative Sandwich ELISA
Validations
  • (1)
N° du produit ABIN2862648
Quantité 96 tests
Fiche technique Fiche technique

Dernières publications sur nos produits Infliximab

Beswick, Rosella, Rosella, Headon, Sparrow, Gibson, van Langenberg: "Exploration of Predictive Biomarkers of Early Infliximab Response in Acute Severe Colitis: A Prospective Pilot Study." dans: Journal of Crohn's & colitis, Vol. 12, Issue 3, pp. 289-297, (2018) (PubMed).

Kang, Choi, Choi, Kim, Kim, Lee, Choe et al.: "Subtherapeutic Infliximab Trough Levels and Complete Mucosal Healing Are Associated With Sustained Clinical Remission After Infliximab Cessation in Paediatric-onset Crohn's Disease Patients Treated ..." dans: Journal of Crohn's & colitis, Vol. 12, Issue 6, pp. 644-652, (2018) (PubMed).

Fleisher, Ait-Oudhia: "A retrospective examination of the US Food and Drug Administration's clinical pharmacology reviews of oncology biologics for potential use of therapeutic drug monitoring." dans: OncoTargets and therapy, Vol. 11, pp. 113-121, (2018) (PubMed).

Ohem, Hradsky, Zarubova, Copova, Bukovska, Prusa, Malickova, Bronsky: "Evaluation of Infliximab Therapy in Children with Crohn's Disease Using Trough Levels Predictors." dans: Digestive diseases (Basel, Switzerland), Vol. 36, Issue 1, pp. 40-48, (2018) (PubMed).

Piñero, Juanola, Gutiérrez, Zapater, Giménez, Steinert, Sempere, González-Navajas, Niess, Francés: "IL26 modulates cytokine response and anti-TNF consumption in Crohn's disease patients with bacterial DNA." dans: Journal of molecular medicine (Berlin, Germany), Vol. 95, Issue 11, pp. 1227-1236, (2018) (PubMed).

Aomori, Tsuchiya, Suzuki, Jibiki, Otsuka, Ishioka, Kaneko, Takeuchi, Nakamura: "Suppression of infliximab antibody levels by azathioprine in patients with rheumatoid arthritis." dans: Die Pharmazie, Vol. 72, Issue 2, pp. 95-97, (2018) (PubMed).

Choi, Kang, Lee, Choe: "Clinical Use of Measuring Trough Levels and Antibodies against Infliximab in Patients with Pediatric Inflammatory Bowel Disease." dans: Gut and liver, Vol. 11, Issue 1, pp. 55-61, (2017) (PubMed).

Bálint, Rutka, Végh, Kürti, Gecse, Banai, Bene, Gasztonyi, Kristóf, Lakatos, Miheller, Palatka, Patai, Salamon, Szamosi, Szepes, Tóth, Vincze, Bor, Milassin, Fábián, Nagy, Kolar, Bortlik, Duricova et al.: "Frequency and characteristics of infusion reactions during biosimilar infliximab treatment in inflammatory bowel diseases: results from Central European nationwide cohort. ..." dans: Expert opinion on drug safety, Vol. 16, Issue 8, pp. 885-890, (2017) (PubMed).

Kolar, Duricova, Bortlik, Hruba, Machkova, Mitrova, Malickova, Lukas, Lukas: "Infliximab Biosimilar (Remsima™) in Therapy of Inflammatory Bowel Diseases Patients: Experience from One Tertiary Inflammatory Bowel Diseases Centre." dans: Digestive diseases (Basel, Switzerland), Vol. 35, Issue 1-2, pp. 91-100, (2017) (PubMed).

Gibellini, De Biasi, Bianchini, Bartolomeo, Fabiano, Manfredini, Ferrari, Albertini, Trenti, Nasi, Pinti, Iannone, Salvarani, Cossarizza, Pellacani: "Anti-TNF-α Drugs Differently Affect the TNFα-sTNFR System and Monocyte Subsets in Patients with Psoriasis." dans: PLoS ONE, Vol. 11, Issue 12, pp. e0167757, (2017) (PubMed).

Vous êtes ici:
Support technique